International guidelines for nosocomial pneumonia: do they cover multidrug resistance management?

V. Del Bono (Genoa, Italy)

Source: International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution
Disease area: Respiratory infections

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Del Bono (Genoa, Italy). International guidelines for nosocomial pneumonia: do they cover multidrug resistance management?. International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Antibiotic resistance and clinical outcomes: the CAPNETZ experience
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006



From international guidelines to local guidelines for nosocomial pneumonia: what is missing?
Source: International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution
Year: 2019


International Guideline concordance of empiric antibiotic use in community-acquired pneumonia
Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Year: 2020



Verifying the antibiotic selection algorithm in the new Japanese pneumonia guidelines - Is algorithm-discordant treatment associated with increased mortality of healthcare-associated pneumonia?
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018


Management of community-acquired pneumonia: new evidence-based algorithms.
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021


Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens
Source: Eur Respir J 2002; 20: 432-439
Year: 2002



Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice.
Source: International Congress 2017 – COPD management
Year: 2017

Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP)
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines
Source: Eur Respir J 2003 Dec 01;22(6):876-882
Year: 2003



Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
Source: Eur Respir J 2011; 38: 878-887
Year: 2011



CAP and HAP guidelines: treatment indications and more
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006



Community acquired pneumonia guidelines: not only treatment indications
Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis
Year: 2004

Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
Source: ERJ Open Res, 4 (2) 00028-2018; 10.1183/23120541.00028-2018
Year: 2018



Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
Source: Guideline 2018
Year: 2019

VAP: approach to therapy
Source: Eur Respir Mon 2011; 53: 36-47
Year: 2011


International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017
Year: 2017



International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Guideline 2017
Year: 2017

Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome
Source: Eur Respir J 2008; 32: 892-901
Year: 2008



Could the initial use of antipseudomonal agents improve the prognosis for non-hospital acquired pneumonia?
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013